biosig.com - נכסים נקיים למניה בודדת BSGM

Despite cost reductions and the threat of delisting, Biosig Technologies (BSGM) is striving for survival. Revenue stability is supported by the supply of consumables to cardiac centers, while growth is based on physicians recognizing the effectiveness of biosignal analysis systems. Fluctuations in the book value per share reflect the dynamics of equity, where -0.12 represents the current level of the metric.

This metric is calculated as the ratio of equity minus intangible assets to the number of shares outstanding, reflecting the actual value of the owner's stake without market noise. The growth in book value per share confirms the capitalization of Biosig Technologies (BSGM) through the implementation of PUREEP systems, converting technological potential into a tangible asset, which makes the price action on this chart a key indicator of the business's fundamental stability.